Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome
about
Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapyΔ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin.Management of hepatitis B virus infection after liver transplantation.Functional Immune Anatomy of the Liver-As an Allograft.
P2860
Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@ast
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@en
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@nl
type
label
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@ast
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@en
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@nl
prefLabel
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@ast
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@en
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@nl
P2093
P2860
P1476
Hepatitis B and liver transpla ...... fluence recurrence and outcome
@en
P2093
Herbert L Bonkovsky
Philippe Zamor
Saeid Shahraz
Tahereh Ghaziani
P2860
P304
14142-14155
P356
10.3748/WJG.V20.I39.14142
P407
P577
2014-10-21T00:00:00Z